UBC is invited to nominate up to two applicants for a Chemical Biology funding initiative from the Ono Pharma Foundation. This opportunity is intended to support early- or mid-career researchers (within 15 years of first academic appointment) with $900k in funding to pursue a novel, innovative research project that could lead to the development of breakthrough treatment solutions for patients.
Given the nomination limit, VPRI will be coordinating an internal section with a deadline of January 16, 2026. Please see the Ono Pharma Initiative or the attached file for more details.
VPRI Contact: Kevin McCartney, Award Nomination Development Officer (kevin.mccartney@ubc.ca)
Departments, divisions, institutes, schools and faculties are strongly encouraged to embed equity, diversity and inclusion (EDI) considerations in their nomination strategies.